[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Biopharma_Watch Avatar @Biopharma_Watch BiopharmaWatch

BiopharmaWatch posts on X about nasdaq, $imab, $osrh, $oncy the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence exchanges XXXX% stocks XXXX% finance XXXX% cryptocurrencies XXXX%

Social topic influence nasdaq 3.06%, $imab 2.04%, $osrh 2.04%, $oncy 2.04%, $tlx 2.04%, $7846t 1.02%, $adtx 1.02%, $cgtx 1.02%, $anvs 1.02%, $rnaz XXXX%

Top assets mentioned Bruker, Corp. (BRKR) Apellis Pharmaceuticals, Inc. Common Stock (APLS) IDEAYA Biosciences, Inc. Common Stock (IDYA) Alkermes Inc. plc (ALKS) Regeneron Pharmaceuticals Inc (REGN) Bristol-Myers Squibb Co (BMY) Public Masterpiece Token (PMT) Oobit (OBT) GLOBUS MEDICAL INC (GMED)

Top Social Posts #

Top posts by engagements in the last XX hours

"$ADTX 1.31$ XXXX% July XX 2025 Aditxts Subsidiary Pearsanta Receives an Invitation to Submit Full Proposal for the U.S. Department of Defense Pilot Award for the Development of its Mitomic Ovarian Test"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-24 15:45:08 UTC XXX followers, XX engagements

"Top Market Movers: Positive News Full Access: $CGTX 0.75$ XXXX% July XX 2025 Cognition Therapeutics Publishes Proteomic Analysis Elucidating Zervimesines Protection of Neurons and Synapses in Alzheimers Disease"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-22 15:45:02 UTC XXX followers, XXX engagements

"Latest catalysts: $ANVS Catalyst Date - 2025-07-27 Drug - buntanetap Treatment - Alzheimer's disease"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-25 15:45:03 UTC XXX followers, XXX engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $ANEB - 689.0K - 20.1M - XXXXX $CLSD - 8.3M - 227.9M - XXXXX $RNAZ - 164.0K - 4.2M - 25.42"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-24 15:45:03 UTC XXX followers, XXX engagements

"$APYX 2.48$ XXXX% July XX 2025 Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2025 Financial Results on August X 2025"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-25 15:45:08 UTC XXX followers, XX engagements

"Sionna Therapeutics (NASDAQ: $SION) is making waves in a tough biotech IPO market. The company just raised $219M in its IPO targeting cystic fibrosis (CF) with a novel undruggable approach. Their therapies could restore near-normal CFTR function for over XX% of CF patients addressing gaps left by current treatments. Key points: Positive Phase X data for lead candidates SION-719 and SION-451 with Phase 2a trials starting soon Global CF therapy market projected to reach $39B by 2034 Strong cash runway through 2028 all analysts rate Sionna a Buy Major milestone: mid-2026 clinical data readout"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-24 16:58:33 UTC XXX followers, XXX engagements

"$BRKR 35.80$ -XXXXX% July XX 2025 Bruker Announces Second Quarter 2025 Preliminary Results Plans to Hold Q2 Earnings Conference Call on August X 2025"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-21 15:45:06 UTC XXX followers, XX engagements

"Latest catalysts: $IMAB Catalyst Date - 2025-07-08 Drug - Givastomig (TJ033721 / ABL111) Treatment - Claudin 18.2-positive gastric cancers"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-07 15:45:04 UTC XXX followers, XXX engagements

"Top Market Movers: Positive News Full Access: $OSRH 1.01$ XXXX% July XX 2025 OSR Holdings Enters into Term Sheet to Acquire Woori IO a Pioneer in Noninvasive Glucose Monitoring Technology"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-25 15:45:02 UTC XXX followers, XXX engagements

"$APLS Catalyst Date - 2025-07-28 Drug - EMPAVELI (pegcetacoplan) Treatment - C3 glomerulopathy primary immune complex membranoproliferative glomerulonephritis"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-25 15:45:14 UTC XXX followers, XXX engagements

"$IDYA 23.27$ XXXX% July XX 2025 IDEAYA Biosciences and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849) a Potential First-in-Class DLL3-TOP1 ADC"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-23 15:45:08 UTC XXX followers, XX engagements

"Top Market Movers: Positive News Full Access: $PSTV 0.62$ XXXXX% July XX 2025 Plus Therapeutics Announces $XXX Million Advance Payment from CPRIT"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-24 15:45:02 UTC XXX followers, XXX engagements

"Latest catalysts: $IMAB Catalyst Date - 2025-07-02 Drug - Givastomig (Claudin XXXX x 4-1BB bispecific antibody) Treatment - Claudin 18.2-positive metastatic gastric cancers"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-01 15:45:03 UTC XXX followers, XXX engagements

"Top Market Movers: Negative News Full Access: $EVO 3.66$ -XXXXX% July XX 2025 Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-21 15:45:03 UTC XXX followers, XXX engagements

"$ALKS 26.50$ -XXXX% July XX 2025 Alkermes Announces Positive Topline Results From Vibrance-1 Phase X Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-21 15:45:09 UTC XXX followers, XXX engagements

"$ONCY 1.18$ -XXXX% July XX 2025 Oncolytics Biotech Regains Compliance with Nasdaq Trading Rules"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-23 15:45:09 UTC XXX followers, XX engagements

"$ONCY 1.18$ -XXXX% July XX 2025 Oncolytics Biotech Regains Compliance with Nasdaq Trading Rules"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-23 15:45:13 UTC XXX followers, XXX engagements

"$OSRH 1.08$ XXXX% July XX 2025 OSR Holdings Enters into Term Sheet to Acquire Woori IO a Pioneer in Noninvasive Glucose Monitoring Technology"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-24 15:45:10 UTC XXX followers, XXX engagements

"$ATYR 6.71$ XXXXX% July XX 2025 aTyr Pharma Announces Last Patient Visit in Phase X EFZO-FIT Study of Efzofitimod in Patients with Pulmonary Sarcoidosis"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-23 15:45:02 UTC XXX followers, XXX engagements

"Top Market Movers: Positive News Full Access: $ABVX 65.61$ XXXXXX% July XX 2025 Abivax Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod its First-in-Class Oral miR-124 En"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-23 15:45:02 UTC XXX followers, XXX engagements

"Top Market Movers: Negative News Full Access: $TLX 14.47$ -XXXXX% July XX 2025 Telix Reports $204M Revenue Up XX% YOY"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-23 15:45:03 UTC XXX followers, XXX engagements

"Upcoming catalysts to watch in April 2025 📅: $RAPT $PMN $CLNN $GNTA $BOLD $THTX $REGN $BMY $NBTX $AMPG $BCAK $EOSI $EVAX $TLX $OCGN $SNTI $KURA $PMT $OBT For detailed insights 📷"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-04-06 11:37:00 UTC XXX followers, XXX engagements

"$GMED 53.30$ XXXX% July XX 2025 Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results"
@Biopharma_Watch Avatar @Biopharma_Watch on X 2025-07-22 15:45:12 UTC XXX followers, XXX engagements